Drug Profile
Drospirenone/ethinylestradiol low-dose - Bayer HealthCare Pharmaceuticals
Alternative Names: BAY86-5300; BAY86-5300-YAZ-Flex; Dihydrospirorenone/ethinylestradiol low-dose; Drospirenone/ethinyl estradiol; EE20/Drospirenone; EE20/DRSP; Ethinylestradiol-Drospirenone 24+4; Flexyess; SH-T-00186D; Yasmin® 20; Yasminelle; Yaz; Yaz 24+4; Yaz Extended Cycle; YAZ Extended Regimen; Yaz Flex; YviduallyLatest Information Update: 15 Apr 2021
Price :
$50
*
At a glance
- Originator Bayer HealthCare Pharmaceuticals; Bayer Schering Pharma
- Developer Bayer HealthCare Pharmaceuticals; Bayer HealthCare Pharmaceuticals Inc.
- Class Alkylated estrogenic steroids; Androstenes; Norpregnatrienes; Oral contraceptives; Progesterone congeners; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acne; Dysmenorrhoea; Pregnancy; Premenstrual dysphoric disorder; Premenstrual syndrome
- Discontinued Endometriosis
Most Recent Events
- 15 Apr 2021 Discontinued - Phase-III for Acne in China (PO)
- 15 Apr 2021 Discontinued - Phase-III for Endometriosis in Japan (PO)
- 15 Apr 2021 Discontinued - Phase-III for Premenstrual dysphoric disorder in China (PO)